ADVFN - Advanced Financial Network.
HOME» NYSE » A » ABT Stock Price » ABT Stock News

Abbott Labs Share News

 Abbott Laboratories Stock Price
ABT Stock Price
 Abbott Laboratories Stock Chart
ABT Stock Chart
 Abbott Laboratories Stock News
ABT Stock News
 Abbott Laboratories Company Information
ABT Company Information
 Abbott Laboratories Stock Trades
ABT Stock Trades

Applications Given Early Antitrust Clearance

The Hart-Scott-Rodino Act requires under certain circumstances that prospective acquirers of voting securities or assets apply for clearance from regulators. Requests for early termination or clearance are granted when the Federal Trade Commission and the antitrust division of the Department of Justice have determined that they won't take action during the waiting period. The following is a list of companies or people to which the FTC has granted early clearance of antitrust concerns under the HSR Act: NAME OF ACQUIRING PERSON NAME OF ACQUIRED PERSON DATE NAME OF ACQUIRED ENTITY TERMINATED _____________________________________________________________ Johnson & Johnson Monday Synthes, Inc. Synthes, Inc. Abbott Laboratories Monday Action Pharma A/S Action Pharma A/S Silicon Laboratories Inc. Monday Ember Corporation Ember Corporation UANT Ventures, L.L.P. Monday Urology Associates of North Texas, L.L.P. Urology Associates of North Texas, L.L.P. Smart Balance, Inc. Monday Allan B. Hubbard Udi's Healthy Foods, LLC Order free Annual Report for Abbott Laboratories Visit http://djnewswires.ar.wilink.com/?link=ABT or call 1-888-301-0513 Order free Annual Report for Johnson & Johnson Visit http://djnewswires.ar.wilink.com/?link=JNJ or call 1-888-301-0513 Order free Annual Report for Silicon Laboratories, Inc. Visit http://djnewswires.ar.wilink.com/?link=SLAB or call 1-888-301-0513 Order free Annual Report for Smart Balance, Inc. Visit http://djnewswires.ar.wilink.com/?link=SMBL or call 1-888-301-0513

Stock News for Abbott Labs (ABT)
DateTimeHeadline
05/14/201310:21:08AbbVie, Alvine Pharma to Collaborate on Investigational Drug...
05/10/201317:20:41AbbVie Chief Scientific Officer John Leonard to Retire
04/30/201317:43:33BOND REPORT: Apple Prices $17 Bln Bond Deal To Strong Demand
04/30/201314:38:57BOND REPORT: Apple Launches $17 Bln Bond Deal
04/30/201313:47:14BOND REPORT: Apple Sees High Demand For Bond Offering
04/30/201311:58:44Auction of Brazilian Drug Company Ache Stalls on Differences...
04/26/201308:50:10AbbVie Profit Rises, Boosted by Humira Sales
04/26/201308:39:21AbbVie 1st-Quarter Profit Rises 9.6% on Strong Sales of Humira
04/23/201310:01:52Health-Care Companies Report Slowdown in Patient Visits
04/17/201308:42:49Abbott 1st-Quarter Profit Fell 56% On Spinoff; Remaining Operations...
04/15/201307:50:35Abbott Laboratories Recalls FreeStyle InsuLinx Glucose Meters
04/12/201309:01:10Elan Investors Back Buyback, As Takeover Speculation Swirls
04/05/201309:08:58U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
04/04/201317:00:42Appeals Court Reverses $593 Million Award Against J&J
04/04/201316:25:26U.S. Appeals Court Reverses $593 Million Award Against J&J
03/22/201315:50:41Abbott Labs Issues Safety Alert on MitraClip Heart-Valve Device
03/20/201319:01:03FDA Panel Votes 5-3 on Benefits of Abbott Heart Device Mitraclip
03/18/201311:00:33AbbVie CEO 2012 Compensation Valued at $7.9 Million, Up More...
03/18/201308:50:01FDA Recommends Against Approving Abbott's Mitraclip Heart Device
03/05/201300:31:11Rise of Generics, Specialty Drugs Prompt Shift in Drug Spending

Abbott Laboratories and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad